The model was expanded to include experimental quantification of VEGF receptor density, VEGF degradation and VEGF secretion by tumour cells, and a sensitivity study was performed to determine the model parameters that influence the response to anti-VEGF treatment. This evidence concerns the gene VEGFA and neoplasm.